Decibel Therapeutics Common Stock

Decibel Therapeutics (DBTX) currently reports a common stock of $25K as of June 2023. That compares with $25K in the prior-year period — up 0.0% year over year. Use the charts on this page to explore Decibel Therapeutics's common stock history and peer comparisons.

Decibel Therapeutics's common stock was unchanged from $25K to $25K — essentially flat versus a year earlier (period ending June 2023). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Decibel Therapeutics reported $25K in common stock as of June 2023. That compares with $25K in the prior-year period — up 0.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current common stock of $25K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Decibel Therapeutics, and consider following DBTX for alerts when major investors trade the stock.

Decibel Therapeutics is classified in the Healthcare sector. On common stock, it currently shows $25K. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing DBTX with unrelated industries.